REGISTERED NUMBER: 15209079 (England and Wales)

Unaudited Financial Statements for the Year Ended 31st October 2025

for

Wicks Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

P Wicks

REGISTERED OFFICE:

The Lexicon

10-12 Mount Street

Manchester

United Kingdom

M2 5NT

BUSINESS ADDRESS:

36 Hyde Abbey Road

Winchester

Hampshire

SO23 7DA

REGISTERED NUMBER:

15209079 (England and Wales)

ACCOUNTANTS:

Veritas Accountants & Advisory Limited

The Lexicon

Mount Street

Manchester

M2 5NT

FIXED ASSETS

Investments

4

1,500

-

CURRENT ASSETS

Debtors

5

-

3,435

Cash at bank

77,078

40,086

77,078

43,521

CREDITORS

Amounts falling due within one year

6

10,458

9,154

NET CURRENT ASSETS

66,620

34,367

TOTAL ASSETS LESS CURRENT LIABILITIES

68,120

34,367

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

68,020

34,267

SHAREHOLDERS' FUNDS

68,120

34,367

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28th July 2026 and were signed by:

P Wicks - Director

1.	COMPANY INFORMATION

Wicks Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	FIXED ASSET INVESTMENTS

Interest

in other

participating

interests

£

COST

Additions

1,500

At 31st October 2025

1,500

NET BOOK VALUE

At 31st October 2025

1,500

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.10.25

31.10.24

£

£

Trade debtors

-

3,435

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.10.25

31.10.24

£

£

Amounts owed to associates

1,117

-

Tax

8,035

8,273

Directors' current accounts

500

75

Accrued expenses

806

806

10,458

9,154

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.10.25

31.10.24

value:

£

£

100

Share Capital

1

100

100

8.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31st October 2025 and the period ended 31st October 2024:

31.10.25

31.10.24

£

£

P Wicks

Balance outstanding at start of year

(75

)

-

Amounts advanced

75

600

Amounts repaid

(500

)

(675

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(500

)

(75

)

9.	ULTIMATE CONTROLLING PARTY

The controlling party is P Wicks.